XML 72 R43.htm IDEA: XBRL DOCUMENT v3.6.0.2
Quarterly Financial Data (unaudited) (Tables)
12 Months Ended
Dec. 31, 2016
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Data
The following tables contain selected unaudited consolidated statements of operations data for each quarter of 2016 and 2015 (in thousands, except per share data):
 
Quarters Ended
 
Fiscal 2016
April 2,
2016
 
July 2,
2016
 
October 1,
2016
 
December 31,
2016
 
Total revenue
$
171,167

 
$
172,636

 
$
167,621

 
$
183,201

 
Gross profit
114,213

 
115,135

 
110,122

 
124,329

 
Operating income
37,337

 
36,429

 
36,604

 
310,400

(1) 
Net income attributable to Masimo Corporation stockholders
27,577

 
30,023

 
27,773

 
215,293

(2) 
Net income per share attributable to Masimo Corporation stockholders:
 
 
 
 
 
 
 
 
Basic (3)
$
0.56

 
$
0.61

 
$
0.56

 
$
4.31

 
Diluted (3)
$
0.53

 
$
0.57

 
$
0.52

 
$
3.97

 
(1) On November 5, 2016, the Company entered into the Philips Settlement Agreement, pursuant to which Philips N.V. agreed to pay the Company $300 million. Per the terms of the agreement, $270 million of this settlement is included within Operating income for the quarter ended December 31, 2016. See Note 2 - Summary of Significant Accounting Policies under the subheading “Litigation Costs and Contingencies” and Note 15 - Commitments and Contingencies under the subheading “Litigation” for additional information on the Phillips Settlement Agreement.
(2)               The Company early adopted Accounting Standards Update No. 2016-09, Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting (ASU 2016-09) during the quarter ended April 2, 2016. The early adoption of ASU 2016-09 increased net income for the quarters ended April 2, 2016, July 2, 2016, October 1, 2016 and December 31, 2016 by $1.0 million, $4.1 million, $2.6 million and $5.2 million, respectively.
(3) Due to the significant impact of the Philips Settlement Agreement on the fourth quarter results, the sum of the basic and diluted earnings per share numbers for each quarter will not equal the basic and diluted earnings per share number for the entire year.
 
Quarters Ended
 
Fiscal 2015
April 4,
2015
 
July 4,
2015
 
October 3,
2015
 
January 2,
2016
 
Total revenue
$
154,537

 
$
155,726

 
$
152,575

 
$
167,273

 
Gross profit
103,105

 
102,901

 
102,232

 
101,745

 
Operating income
27,377

 
27,841

 
28,140

 
36,892

(2) 
Net income attributable to Masimo Corporation stockholders
20,523

 
19,351

 
19,325

 
24,101

 
Net income per share attributable to Masimo Corporation stockholders:
 
 
 
 
 
 
 
 
Basic
$
0.39

 
$
0.38

 
$
0.38

 
$
0.48

 
Diluted
$
0.38

 
$
0.36

 
$
0.36

 
$
0.46

 
(2) On November 16, 2015, we entered into a Settlement Agreement with Shenzhen Mindray Biomedical Electronics Co., Ltd. and certain of its affiliates (collectively, Mindray), pursuant to which Mindray agreed to pay the Company $25 million, which has been included within Operating income for the quarter ended January 2, 2016.